Sign in
4

Changes in Ownership

TransMedics Group, Inc. Filed Acc 0000899243-22-036016

Chief Commercial Officer sold 4,254 shares at $60.06 ($255,495)

  • Chief Commercial Officer acquired 4,254 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Khayal Tamer I Chief Commercial Officer 2022-11-15 Option exercise +4,254 $2.21 $9,401 5,554 D: show line 1 in the form
Khayal Tamer I Chief Commercial Officer 2022-11-15 Sale −4,254 $60.06 $255,495 1,300 D: show line 2 in the form
Open-market sales · 4,254 sh · avg $60.06 · $255,495

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Khayal Tamer I Chief Commercial Officer 2022-11-15 Option exercise · Stock Option (Right to Buy) −4,254 11,051 D: show line 3 in the form
Loading xslF345X03/doc4.xml…